-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Maintains Buy on PROCEPT BioRobotics, Lowers Price Target to $28

Benzinga·08/05/2026 19:44:01
Listen to the news
TD Cowen analyst Joshua Jennings maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Buy and lowers the price target from $34 to $28.